ArticleFrontiers in cardiovascular medicine2026
Implementation of a national rheumatic fever and rheumatic heart disease prevention and control program in Egypt: rationale and objectives.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Rheumatic heart disease (RHD) remains a major public health challenge in Egypt, with a school-age prevalence of 0.9%-2.5%. Despite national initiatives since 2006, control has been constrained by low public and provider awareness, suboptimal secondary prophylaxis, misdiagnosis, and fragmented surveillance. This report outlines the rationale and structure of Egypt's national RF/RHD prevention and control program, which integrates screening, digital surveillance, capacity building, and research to support scalable RHD control in endemic settings. Methods: The program comprises (1) mandatory RF notification and a national electronic registry for public-sector cases and screening positives; (2) nationwide school-based echocardiographic screening of >10,000 children across 27 governorates using standardized clinical examination and World Heart Federation criteria; (3) Characterization of regional patterns and determinants of RHD; (4) Development of region-specific risk stratification tools, guidelines, diagnostic criteria and prevention strategies; (5) nationwide multimedia awareness campaigns; (6) Capacity building through continuous medical education and training at all care levels; and (7) and embedded high-impact research and clinical trials. Conclusions: Egypt's national RF/RHD prevention and control program provides a comprehensive and scalable framework that combines school-based screening, mandatory notification, a national registry, workforce training, public awareness, and embedded research to improve case detection, support timely prophylaxis, and generate local evidence for risk stratification and policy, modelling an approach suitable for other endemic settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.